Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1-(beta-(4''-chlorobenzylthio)-2'4'-dichlorophenethyl)imidazole
2. Exelderm
3. Myk
4. Sulconazole Mononitrate
5. Sulconazole Nitrate
6. Sulconazole, Mononitrate, (+-)-isomer
1. 61318-90-9
2. Sulconazolum
3. Sulconazol
4. Sulconazolum [inn-latin]
5. 1-(2-((4-chlorobenzyl)thio)-2-(2,4-dichlorophenyl)ethyl)-1h-imidazole
6. Sulconazol [inn-spanish]
7. (+/-)-sulconazole
8. 1-[2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole
9. 5d9haa5q5s
10. Chebi:77776
11. Sulconazole (inn)
12. 1-{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl}-1h-imidazole
13. Sulconazole [inn]
14. 1-[2-(4-chloro-benzylsulfanyl)-2-(2,4-dichloro-phenyl)-ethyl]-1h-imidazole
15. Sulconazole [inn:ban]
16. Unii-5d9haa5q5s
17. 1h-imidazole, 1-(2-(((4-chlorophenyl)methyl)thio)-2-(2,4-dichlorophenyl)ethyl)-
18. 1h-imidazole, 1-[2-[[(4-chlorophenyl)methyl]thio]-2-(2,4-dichlorophenyl)ethyl]-
19. Spectrum_001416
20. Sulconazole [mi]
21. Prestwick0_000810
22. Prestwick1_000810
23. Prestwick2_000810
24. Prestwick3_000810
25. Spectrum2_001422
26. Spectrum3_001457
27. Spectrum4_000436
28. Spectrum5_001155
29. Sulconazole [vandf]
30. Chembl1221
31. Schembl34761
32. Bspbio_000679
33. Bspbio_002953
34. Kbiogr_000792
35. Kbioss_001896
36. Sulconazole [who-dd]
37. Cid_65495
38. Divk1c_000220
39. Spbio_001524
40. Spbio_002600
41. Bpbio1_000747
42. Dtxsid8044129
43. Bdbm31770
44. Hy-b1460b
45. Kbio1_000220
46. Kbio2_001896
47. Kbio2_004464
48. Kbio2_007032
49. Kbio3_002453
50. Ninds_000220
51. (+-)-1-(2,4-dichlor-beta-((4-chlorbenzyl)thio)phenethyl)imidazol
52. (+-)-1-(2,4-dichloro-beta-((p-chlorobenzyl)thio)phenethyl)imidazole
53. Akos015961204
54. Db06820
55. 1h-imidazole, 1-(2-(((4-chlorophenyl)methyl)thio)-2-(2,4-dichlorophenyl)ethyl)-, (+-)-
56. Idi1_000220
57. Ncgc00018250-02
58. Ac-13116
59. Sbi-0051660.p002
60. Db-053840
61. Ab00053607
62. Cs-0013811
63. Ft-0630725
64. C08076
65. D08535
66. Ab00053607_16
67. Ab00053607_17
68. Q2392530
69. Brd-a70649075-008-05-0
70. Brd-a70649075-008-17-5
71. 1-[2,4-dichloro-beta-(4-chlorobenzylthio)phenethyl]imidazole
72. 1-[beta-[(4-chlorobenzyl)thio]-2,4-dichlorophenethyl]-1h-imidazole
73. 1-(2-(4-chlorobenzylthio)-2-(2,4-dichlorophenyl)ethyl)-1h-imidazole
74. 1-(2-(((4-chlorophenyl)methyl)thio)-2-(2,4-dichlorophenyl)ethyl)-1h-imidazole
75. 1h-imidazole, 1-[2-[[(4-chlorophenyl)methyl]thio]-2-(2,4-dichlorophenyl)ethyl]-(9ci)
76. 1h-imidazole, 1-(2-(((4-chlorophenyl)methyl)thio)-2-(2,4-dichlorophenyl)ethyl)-, (+/-)-
| Molecular Weight | 397.7 g/mol |
|---|---|
| Molecular Formula | C18H15Cl3N2S |
| XLogP3 | 6.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 6 |
| Exact Mass | 396.002153 g/mol |
| Monoisotopic Mass | 396.002153 g/mol |
| Topological Polar Surface Area | 43.1 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 379 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Sulconazole solution 1.0% is indicated for the treatment of tinea cruris and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis; and for the treatment of tinea versicolor. Effectiveness has not been proven in tinea pedis (athletes foot).
FDA Label
The function of imidazole derivatives can be attributed to their structural resemblance to purines essential to metabolism.
Antifungal Agents
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
D01AC09
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
D - Dermatologicals
D01 - Antifungals for dermatological use
D01A - Antifungals for topical use
D01AC - Imidazole and triazole derivatives
D01AC09 - Sulconazole
Absorption
Total sulconazole systemic absorption after topical administration was ~8.71% of the dose.
Route of Elimination
About 6.70% of the dose was recovered in urine, and 2.01% in feces over a 7 day collection period. Radioactivity could be detected in both urine and feces at 7 days potentially due to a reservoir effect.
ABOUT THIS PAGE
66
PharmaCompass offers a list of Sulconazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sulconazole manufacturer or Sulconazole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sulconazole manufacturer or Sulconazole supplier.
PharmaCompass also assists you with knowing the Sulconazole API Price utilized in the formulation of products. Sulconazole API Price is not always fixed or binding as the Sulconazole Price is obtained through a variety of data sources. The Sulconazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sulconazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sulconazole, including repackagers and relabelers. The FDA regulates Sulconazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sulconazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sulconazole supplier is an individual or a company that provides Sulconazole active pharmaceutical ingredient (API) or Sulconazole finished formulations upon request. The Sulconazole suppliers may include Sulconazole API manufacturers, exporters, distributors and traders.
Sulconazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sulconazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sulconazole GMP manufacturer or Sulconazole GMP API supplier for your needs.
A Sulconazole CoA (Certificate of Analysis) is a formal document that attests to Sulconazole's compliance with Sulconazole specifications and serves as a tool for batch-level quality control.
Sulconazole CoA mostly includes findings from lab analyses of a specific batch. For each Sulconazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sulconazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Sulconazole EP), Sulconazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sulconazole USP).
